Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

BACKGROUND: Patients with high‐intermediate risk endometrial cancer (H‐IR EMCA) have an elevated risk of recurrence compared to low‐risk counterparts. Many H‐IR EMCA patients are treated with radiation or chemotherapy, but their overall survival is not significantly impacted by treatment. The object...

Descripción completa

Detalles Bibliográficos
Autores principales: Arend, Rebecca C., Scalise, Carly B., Dholakia, Jhalak, Kamal, Maahum Z., Thigpen, Haley B., Crossman, David, Huh, Warner K., Leath, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinfomatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607249/
https://www.ncbi.nlm.nih.gov/pubmed/34729947
http://dx.doi.org/10.1002/cam4.4247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607249/
https://www.ncbi.nlm.nih.gov/pubmed/34729947
http://dx.doi.org/10.1002/cam4.4247

Ejemplares similares